Abdul Moiz Khan

Dr. Abdul Moiz Khan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
NJNandan Joshi
Nandan Joshi
KBKanwal Mir Baloch
Kanwal Mir Baloch
SRShah Rukh
Shah Rukh
AKAbdul Moiz Khan
Abdul Moiz Khan
FMFnu Muskan
Fnu Muskan
FGFenil Gandhi
Fenil Gandhi
Diabetes mellitus (DM) is a long-term metabolic disorder caused by inadequate production and resistance to insulin. The prevalence of DM is rapidly increasing, with type 2 diabetes (T2D) accounting for more than 90% of cases. Despite new treatments, many patients with T2D do not meet their glycemic targets due to clinical inertia. This review provides an overview of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in the management of T2D. The review synthesizes data from clinical trials and meta-analyses on the efficacy, safety, and cost-effectiveness of GLP-1 RAs. It also discusses the mechanisms of action, classification, and barriers to adherence and persistence in therapy. GLP-1 RAs improve glycemic control by lowering A1C levels and promoting weight loss. They have cardioprotective effects and may reduce endothelial inflammation, oxidative stress, and blood pressure. Adherence to GLP-1 RAs is better with once-weekly injections, though gastrointestinal side effects and cost can affect persistence. Semaglutide and liraglutide have shown significant weight reduction, with semaglutide being particularly effective. GLP-1 RAs are cost-effective due to reduced healthcare costs associated with fewer hospitalizations and lower mortality rates. Safety concerns include gastrointestinal issues, pancreatitis, and rare cases of diabetic retinopathy and thyroid C-cell tumors. For clinical practice, GLP-1 RAs represent a valuable option not only for glycemic control but also for weight management and cardiovascular protection. Incorporating GLP-1 RAs into treatment plans can improve patient outcomes, and optimizing dosing regimens and addressing barriers such as cost and side effects are crucial to enhancing patient adherence and long-term treatment success.

5 October 2025 in Clinical Case Reports
Verified
Journal Article
Open access
AKAbdul Moiz Khan
Abdul Moiz Khan
SSSyed Wajihullah Shah
Syed Wajihullah Shah
QSQazi Muhammad Safwan
Qazi Muhammad Safwan
RARida Akhtar
Rida Akhtar
JIJibran Ikram
Jibran Ikram
MBMuhammad Abu Bakkar
Muhammad Abu Bakkar
Myoepitheliomas are rare salivary gland tumors, comprising only 1%–1.5% of all cases. We report a unique case of a 69‐year‐old woman with a painless, slowly enlarging right parotid mass. CT imaging showed an ill‐defined, irregular, multilobulated heterogeneous lesion compressing the deep parotid lobe. Fine‐needle aspiration cytology suggested a benign spindle cell tumor. The patient underwent superficial parotidectomy, and histopathology confirmed a benign myoepithelioma with spindle and epithelioid cells, along with distinctive fibro‐myxoid changes. Immunohistochemistry was positive for p63 and S‐100. Postoperative recovery was uneventful, and no recurrence was noted at two‐year follow‐up. This case highlights the importance of considering myoepithelioma in elderly patients and demonstrates distinct radiological and histological features aiding diagnosis.

8 October 2024 in Cureus
Verified
Journal Article
Open access
PDF file
AKAbdul Moiz Khan
Abdul Moiz Khan
AEAmna Ehtisham
Amna Ehtisham
HCHumais Habib Choudhary
Humais Habib Choudhary
HHHumais Habib
Humais Habib
This case report details a 40-year-old male patient with a background of ulcerative colitis (UC), who presented with persistent bloody diarrhea refractory to standard treatment. The clinical picture was initially suggestive of a UC flare-up, prompting the continued use of immunosuppressive therapy. However, histopathological evaluation ultimately revealed cytomegalovirus (CMV) colitis, a condition that can mimic UC exacerbation but requires a distinct treatment approach. The patient’s immunosuppressive therapy, essential for UC management, likely contributed to the reactivation of latent CMV infection, underscoring the complexity of managing such cases. This case underscores the critical importance of a multidisciplinary approach in differentiating between UC exacerbation and opportunistic infections such as CMV colitis, especially in immunocompromised patients.

17 August 2025 in Cureus
Verified
Journal Article
Open access
PDF file
AKAbdul Moiz Khan
Abdul Moiz Khan
RARehan Ali
Rehan Ali
SNSaliq Naeem
Saliq Naeem
AEAmna Ehtisham
Amna Ehtisham
SRShah Rukh
Shah Rukh
Ewing sarcoma (ES) is a small, round, blue cell malignant neoplasm that rarely occurs in the craniofacial skeleton, with presentation in the maxilla being exceedingly rare. We report the case of a 14-year-old girl with a two-year history of slowly progressive facial swelling that has recently become greatly enlarged. Imaging revealed an aggressive expansile left maxillary lesion with soft-tissue involvement and internal calcifications. Surgical resection was performed, and histopathological analysis showed sheets of homogenous round cells with minimal cytoplasm and round nuclei. Immunohistochemical staining for CD99, CD56, and NKX2.2 was positive, while staining for epithelial, muscle, and neural markers was negative, thereby confirming the diagnosis of ES. This case highlights the diagnostic difficulty of ES in unusual sites such as the maxilla, where it can mimic odontogenic or fibro-osseous lesions. Early diagnosis with histopathology and immunohistochemistry is important for appropriate management, which usually includes surgical resection followed by chemotherapy.

14 April 2025
Verified
Preprint
Open access
AKAbdul Moiz Khan
Abdul Moiz Khan
SSSyed Wajihullah Shah
Syed Wajihullah Shah
QSQazi Muhammad Safwan
Qazi Muhammad Safwan
RARida Akhtar
Rida Akhtar
JIJibran Ikram
Jibran Ikram
MBMuhammad Abu Bakkar
Muhammad Abu Bakkar

8 August 2025 in Cureus
Verified
Journal Article
Open access
PDF file
AKAbdul Moiz Khan
Abdul Moiz Khan
SNSaliq Naeem
Saliq Naeem
AEAmna Ehtisham
Amna Ehtisham
RARehan Ali
Rehan Ali
HMHamais Murtaza
Hamais Murtaza
BCOR-rearranged sarcoma is a rare mesenchymal tumor and a recognized subtype of undifferentiated small round-cell sarcoma. It shares morphological similarities with other round-cell sarcomas but is distinguished by a unique molecular hallmark that differentiates it from Ewing sarcoma. These tumors primarily arise in bones and soft tissues. This case report details the case of an 11-year-old female who developed swelling on the medial aspect of her right distal thigh. There was no history of trauma, surgery, or fracture. Clinically, the presentation initially suggested osteosarcoma. However, histopathological evaluation confirmed a diagnosis of BCOR-rearranged sarcoma. This case highlights the importance of considering BCOR-rearranged sarcoma in the differential diagnosis of pediatric bone and soft tissue tumors, as its clinical and radiological features can mimic more common malignancies like osteosarcoma. Early recognition and accurate molecular diagnosis are crucial for guiding appropriate treatment.